| layout | title |
|---|---|
work |
Publications and Poster Presentations |
Michal R. Grzadkowski, Hannah D. Holly, Julia Somers, and Emek Demir.
Systematic interrogation of mutation groupings reveals divergent downstream expression programs within key cancer genes.
BMC Bioinformatics (2021)
Michal R. Grzadkowski and Emek Demir.
Exploring Synergistic Relationships in the Mutational Landscape of Prostate Cancer.
Twelfth Annual Prostate Cancer Program Retreat, Fort Lauderdale FL, March 3-5 2019.
Syed Haider, Cindy Q Yao, Vicky S Sabine, Michal Grzadkowski, et al.
Pathway-based subnetworks enable cross-disease biomarker discovery.
Nature Communications (2018)
Michal R. Grzadkowski, Dorota H. Sendorek, Christine P’ng, Vincent Huang & Paul C. Boutros.
A comparative study of survival models for breast cancer prognostication revisited: the benefits of multi-gene models.
BMC Bioinformatics (2018)
Michal R. Grzadkowski and Emek Demir.
Dissecting the Heterogeneity of PIK3CA Mutations in Breast Tumours.
Systems Approaches to Cancer Biology, Woods Hole MA, November 7-10 2018.
E Lalonde, AS Ishkanian, J Sykes, M Fraser, H Ross-Adams, N Erho, MJ Dunning, S Halim, AD Lamb, NC Moon, G Zafarana, AY Warren, X Meng, J Thoms, MR Grzadkowski, et al.
Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study.
The Lancet Oncology (2014)